CAS 133073-73-1|L(+)-Amethopterin hydrate
Introduction：Basic information about CAS 133073-73-1|L(+)-Amethopterin hydrate, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | L(+)-Amethopterin hydrate | ||
|---|---|---|---|
| CAS Number | 133073-73-1 | Molecular Weight | 454.43900 |
| Density | 1.536g/cm3 | Boiling Point | / |
| Molecular Formula | C20H22N8O5 | Melting Point | 195ºC |
| MSDS | ChineseUSA | Flash Point | / |
| Symbol | GHS06, GHS08 | Signal Word | Danger |
Names
| Name | L(+)-Amethopterin hydrate |
|---|---|
| Synonym | More Synonyms |
L(+)-Amethopterin hydrate BiologicalActivity
| Description | Methotrexate (hydrate) is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|---|---|
| Related Catalog | Research Areas >>OthersSignaling Pathways >>Anti-infection >>Bacterial |
Chemical & Physical Properties
| Density | 1.536g/cm3 |
|---|---|
| Melting Point | 195ºC |
| Molecular Formula | C20H22N8O5 |
| Molecular Weight | 454.43900 |
| Exact Mass | 454.17100 |
| PSA | 210.54000 |
| LogP | 1.82170 |
| Vapour Pressure | 0mmHg at 25°C |
| InChIKey | FOBMAFJPPNVNEI-CHNGVTQJSA-N |
| SMILES | CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1.CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1 |
Safety Information
| Symbol | GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301-H315-H319-H360 |
| Precautionary Statements | P201-P301 + P310-P305 + P351 + P338-P308 + P313 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | T |
| Risk Phrases | 61-25-36/38 |
| Safety Phrases | S26-S45-S53-S36-S37 |
| RIDADR | UN 2811 6.1/PG 3 |
| WGK Germany | 3 |
| RTECS | MA1225000 |
Articles353
More Articles| Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells. Br. J. Cancer 111(5) , 874-82, (2014) Standard therapy for acute promyelocytic leukaemia (APL) includes retinoic acid (all-trans retinoic acid (ATRA)), which promotes differentiation of promyelocytic blasts. Although co-administration of ... | |
| Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells. MAbs 7(2) , 403-12, (2015) Linking the heavy chain (HC) and light chain (LC) genes required for monoclonal antibodies (mAb) production on a single cassette using 2A peptides allows control of LC and HC ratio and reduces non-exp... | |
| TLR signaling modulates side effects of anticancer therapy in the small intestine. J. Immunol. 194(4) , 1983-95, (2015) Intestinal mucositis represents the most common complication of intensive chemotherapy, which has a severe adverse impact on quality of life of cancer patients. However, the precise pathophysiology re... |
Synonyms
| MFCD00150848 |
| L-Amethopterin hydrate |
| Methotrexate Hydrate |
